Eupraxia Pharmaceuticals Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Vancouver
EPRX chart
What traders are saying about $EPRX
Latest postsEupraxia Pharmaceuticals Inc. news
- Eupraxia Pharmaceuticals, Inc. Estimates – TSX:EPRX
TradingView ·
- Eupraxia Pharmaceuticals, Inc. (TSX:EPRX): Why Investors Are Reassessing the Next Catalyst for Canadian Market Watchers
kalkine.ca ·
- Eupraxia Pharmaceuticals Inc. (EPRX) stock price, news, quote and history
Yahoo Finance UK ·
- Eupraxia Pharmaceuticals Inc. (TSX:EPRX): Healthcare Investors Reassess the Next Growth Catalyst on the Toronto Market
kalkine.ca ·
- Eupraxia Pharmaceuticals: Promising Science, But Competition And Valuation Limit Upside
Seeking Alpha ·
- Investigational drug EP-104GI will be the focus of Eupraxia (EPRX)'s virtual Analyst Day.
Stock Titan ·
- Eupraxia Pharmaceuticals to present at multiple conferences and host virtual Analyst Day on Nov 13, 2026
Pluang ·
- Eupraxia Pharmaceuticals to Participate at Upcoming Conferences and Host a Virtual Analyst Day
Yahoo Finance ·
- A virtual briefing will cover an experimental injection for an esophagus condition Nov. 13
Stock Titan ·
- Could Eupraxia Pharmaceuticals Inc. Become a TSX Market Watchlist Story? What Investors Need to Know (TSX:EPRX)
kalkine.ca ·
- Eupraxia Pharmaceuticals, Inc. (TSX:EPRX) Extends Bullish Momentum as Investor Interest Strengthens
kalkine.ca ·
- Eupraxia Pharmaceuticals Reaches its Enrollment Target for the RESOLVE Trial Investigating EP-104GI for the Treatment of Eosinophilic Esophagitis
Yahoo Finance ·
Eupraxia Pharmaceuticals Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | – |
| Net income | -$38.6M | -$25.5M | -$28.2M | -$18.5M |
| Diluted EPS | $-1.03 | $-0.76 | $-1.17 | $-0.96 |
| Total assets (year end) | $86.2M | $34.9M | $20.3M | $19.1M |
| Cash and equivalents (year end) | $80.6M | $33.1M | $19.3M | $18.3M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Eupraxia Pharmaceuticals Inc.
- Ticker
- EPRX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Vancouver
- Incorporated in
- British Columbia, Canada
- Fiscal year end
- December 31
- SEC CIK
- 1581178
Frequently asked questions
What exchange is Eupraxia Pharmaceuticals Inc. listed on?
Eupraxia Pharmaceuticals Inc. trades on the Nasdaq under the ticker symbol EPRX.
What industry is Eupraxia Pharmaceuticals Inc. in?
Eupraxia Pharmaceuticals Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Eupraxia Pharmaceuticals Inc. headquartered?
Eupraxia Pharmaceuticals Inc.'s business address on file with the SEC is in Vancouver.
When does Eupraxia Pharmaceuticals Inc.'s fiscal year end?
Eupraxia Pharmaceuticals Inc.'s fiscal year ends on December 31.
How much revenue did Eupraxia Pharmaceuticals Inc. report?
Eupraxia Pharmaceuticals Inc. reported $0 in revenue for calendar year 2025, according to its SEC filings.